Skip to main content
It looks like you're using Internet Explorer 11 or older. This website works best with modern browsers such as the latest versions of Chrome, Firefox, Safari, and Edge. If you continue with this browser, you may see unexpected results.

Levy Library Blog

What's New at The Levy Library | July 2019

by Angelyn Thornton on 2019-07-10T15:38:52-04:00 | Comments


Here at The Levy Library, we are consistently updating our subscriptions to provide the best resources for the communities of Mount Sinai Health System! Check out what's new: 


Reprotox Mobile App

Available for download through iTunes and Google Play, Reprotox is an app that provides fact sheets from the Reproductive Toxicology Center that you can search and read right on your personal device. Reprotox contains summaries on the effects of medications, chemicals, infections, and physical agents on pregnancy, reproduction, and development. Any person with a Mount Sinai email can create an account.


The Carlat Reports

Carlat Publishing provides clear, authoritative, engaging, independent psychiatric education to make you look forward to learning, with the goal of helping you feel smarter, more competent, and more confident in your ability to help your patients become happy. Available newsletters include: The Carlat Psychiatry Report, The Carlat Child Psychiatry Report, and The Carlat Addiction Treatment Report


The Journal of Drugs in Dermatology

The Journal of Drugs in Dermatology (JDD) is a peer-reviewed publication indexed with MEDLINE/PubMed. Founded in 2002, it offers one of the fastest routes to disseminate dermatologic information and is considered the fastest growing publication in dermatology. JDD present original articles, award-winning case reports, and timely features pertaining to new methods, techniques, drug therapy, and devices in dermatology that provide readers with peer reviewed content of the utmost quality.



 Add a Comment



Enter your e-mail address to receive notifications of new posts by e-mail.


  Follow Us

  Return to Blog
This post is closed for further discussion.